Facility-Level Variation in Racial Disparities in Anticoagulation for Atrial Fibrillation: The REACH-AF Study
ConclusionsIn a national cohort of patients with AF, we observed large facility-level variation and adjusted risk differences in any anticoagulant and DOAC initiation, overall and by race. These findings represent a target for local quality improvement in AF care.
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
More News: Atrial Fibrillation | Coumadin | Internal Medicine | Statistics | Stroke | Study | Warfarin